Author:
Oakden-Rayner Luke,Carneiro Gustavo,Bessen Taryn,Nascimento Jacinto C.,Bradley Andrew P.,Palmer Lyle J.
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Collins, F. S. & Varmus, H. A new initiative on precision medicine. New England Journal of Medicine 372, 793–795, doi: 10.1056/NEJMp1500523 (2015).
2. Wild, C. P. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology Biomarkers & Prevention 14, 1847–1850, doi: 10.1158/1055-9965.EPI-05-0456 (2005).
3. Colburn, W. et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Biomarkers Definitions Working Group. Clinical Pharmacol & Therapeutics 69, 89–95 (2001).
4. Wallace, K. et al. Report on the NCSS Fact Finding Cardiotoxicity Expert Working Group. http://www.fda.gov/ohrms/dockets/ac/01/briefing/3798b1_04_holt/sld005.htm (2001).
5. Dancey, J. E., Bedard, P. L., Onetto, N. & Hudson, T. J. The genetic basis for cancer treatment decisions. Cell 148, 409–420, doi: 10.1016/j.cell.2012.01.014 (2012).
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献